Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

VIVUS Inc (NASDAQ:VVUS)

0.5903
Delayed Data
As of Dec 08
 -0.0207 / -3.39%
Today’s Change
0.57
Today|||52-Week Range
1.46
-48.67%
Year-to-Date
No recent news for VIVUS Inc.

Today’s Trading

Previous close0.61
Today’s open0.61
Day’s range0.57 - 0.62
Volume1,592,203
Average volume (3 months)766,513
Market cap$62.5M
Dividend yield--
Data as of 4:00pm ET, 12/08/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-245.45%
Earnings growth (next 5 years)+0.84%
Revenue growth (last year)+30.21%
P/E ratio1.7
Price/Sales0.97
Price/Book3.40

Competitors

 Today’s
change
Today’s
% change
GEMPGemphire Therapeutic...+0.23+2.97%
ALIMAlimera Sciences Inc-0.01-0.76%
MEIPMEI Pharma Inc+0.05+2.25%
ZFGNZafgen Inc+0.08+2.21%
Data as of 4:00pm ET, 12/08/2017

Financials

Next reporting dateFebruary 27, 2018
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$124.3M
Annual profit (last year)$23.3M
Net profit margin18.75%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Seth H. Z. Fischer
Chief Financial &
Accounting Officer
Mark K. Oki
Corporate headquarters
Campbell, California

Forecasts